Medtronic Initiates Clinical Trial for Infuse Bone Graft in TLIF

Medtronic (MDT) received FDA approval for a prospective, randomized pivotal clinical trial on the use of Infuse™ Bone Graft in transforaminal lumbar interbody fusion.

Site recruitment is underway, potentially enrolling over 1,000 subjects at 50 sites.

In 2017, MDT received FDA approval of a separate clinical trial to study Infuse in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us